Last reviewed: June 30, 2026

Last updated: June 30, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide pens arrive pre-filled with fixed amounts of medication, and understanding your supply timeline helps you plan refills and treatment continuity. The standard 1mg Ozempic pen delivers four 0.25mg doses over four weeks, matching the typical maintenance phase dosing schedule used in clinical weight loss trials.

Understanding Your 1mg Semaglutide Pen Supply Duration

A 1mg semaglutide pen contains medication distributed across four weekly injections of 0.25mg each. This one-month supply aligns with the standard maintenance dosing protocol established in GLP-1 receptor agonist clinical trials. Most patients who reach therapeutic benefit stay at this 0.25mg weekly dose, making the 1mg pen the typical ongoing supply size.

The dosing schedule for semaglutide follows a titration pattern during the first month, then stabilizes into weekly injections. During the dose-escalation phase, patients typically inject smaller amounts each week before reaching the 0.25mg maintenance level. Once stabilized, a fresh 1mg pen arrives monthly to maintain consistent weekly dosing.

How Semaglutide Dosing Works Through the First Four Weeks

The initial phase introduces semaglutide gradually to minimize gastrointestinal side effects and allow your body to adapt. Week one begins with a 0.25mg injection, which represents the lowest effective starting dose. Weeks two, three, and four maintain this same 0.25mg dose, establishing your body's tolerance and allowing metabolic pathways to respond.

Some patients require dose escalation beyond the first month based on weight loss response and tolerability. If your healthcare provider recommends advancing your dose, a new pen containing 0.5mg or 1mg concentrations may be prescribed. This gradual titration approach mimics the evidence-based protocols used in randomized controlled trials showing sustained weight reduction.

Comparing Brand Ozempic Pens to PlexusDx Compounded Semaglutide

Brand-name Ozempic pens deliver identical semaglutide through the same injection mechanism, but PlexusDx compounds semaglutide from licensed 503A pharmacies at significantly lower cost. Compounded semaglutide follows the same FDA-established dosing guidelines and injection schedule as brand versions. PlexusDx semaglutide injections start at $189/mo (or $149/mo on the 6-month plan) with no flat per-compound pricing increases—your dose may need to go up, your price won't.

Both brand and compounded options require a prescription and monthly refills to maintain your treatment timeline. PlexusDx serves all 50 states with no insurance requirement, making semaglutide accessible regardless of coverage status. HSA and FSA accounts cover PlexusDx compounded semaglutide, providing additional affordability pathways unavailable with some brand prescriptions.

Planning Your Refill Schedule and Treatment Continuity

A 1mg semaglutide pen lasting exactly one month simplifies refill scheduling—your next dose arrives on the same calendar date each month. Setting a phone reminder one week before your expected refill helps prevent gaps in your weekly injection routine. Missing doses can disrupt metabolic adaptation and reduce the medication's weight loss effectiveness, so consistent monthly supply arrival matters clinically.

The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes GLP1R, GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Ozempic or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $189/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How many injections come in one 1mg semaglutide pen?

A 1mg pen contains four 0.25mg injections delivered over four weeks, with one injection administered each week on the same day. This matches the standard maintenance dosing used in weight loss studies. If your prescriber recommends escalating your dose, you'll receive a new pen with a higher concentration the following month.

What if I need a higher dose than 1mg per week?

Patients requiring dose increases above 0.25mg weekly receive pens containing 0.5mg, 1mg, or 2.4mg concentrations depending on their progression. Your prescriber adjusts your pen strength based on weight loss response and side effect tolerance, not cost—PlexusDx pricing remains flat regardless of dose level. Most patients achieve significant weight reduction at the 0.25mg or 0.5mg maintenance dose.

Does PlexusDx semaglutide follow the same weekly injection schedule as Ozempic?

Yes, PlexusDx compounded semaglutide from licensed 503A pharmacies follows identical dosing protocols and weekly injection schedules as brand Ozempic. The dosing titration, maintenance phases, and refill frequency remain consistent across both options. PlexusDx injections start at $189 per month without insurance, serving all 50 states.

What happens if I miss a weekly semaglutide injection?

Missing one injection can temporarily reduce appetite suppression, but you can resume your normal schedule the following week—do not double dose. Consistent weekly timing optimizes GLP-1 receptor engagement and maintains metabolic benefits demonstrated in clinical trials. Contact your PlexusDx provider if you miss a dose to discuss whether any schedule adjustment is needed.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to Ozempic or any specific medication. It analyzes pathway-level variants (GLP1R, and GIPR) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves